申请人:Vivavision Biotech, Inc.
公开号:EP3777979A1
公开(公告)日:2021-02-17
The present invention provides an anti-inflammatory compound, which is a compound having a structure (I) as shown below:
The compound is a target that is important for autoimmune activation, and that has strong inhibitory effect on PDE4 and penetrates the skin easily, and is a new type anti-inflammatory compound that is easily degraded.
本发明提供了一种抗炎化合物,它是一种具有如下所示结构(I)的化合物:
该化合物以自身免疫活化为重要靶点,对 PDE4 有较强的抑制作用,易渗透皮肤,是一种易降解的新型抗炎化合物。